NxThera
Edit

NxThera

http://www.nxthera.com/
Last activity: 03.12.2018
Tags:HardwareMedtech
Develops medical technologies to treat a variety of endourological conditions, including BPH, prostate cancer and kidney cancer.
Location: United States, Minnesota, Maple Grove
Total raised: $53.6M

Investors 2

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
03.12.2015-$40M-finsmes.co...
17.03.2011Series B$12.6M-finsmes.co...
03.08.2010-$1M-medcitynew...

Mentions in press and media 20

DateTitleDescriptionSource
03.12.2018NxThera spinout NxPhase lands $10m for vapor ablation techNxPhase Medical – spun out of NxThera when Boston Scientific bought it this year– has raised more th...massdevice...
03.12.20185 Startup Trends that Shaped the Midwest in 2018 1. Marketp...2018 is quickly drawing to its close, but the Midwest’s venture capital activity is still buzzing. J...hpa.vc/5-s...
29.11.20185 startup trends that shaped the Midwest in 20182018 is quickly drawing to its close, but the Midwest’s venture capital activity is still buzzing. J...venturebea...
29.11.20185 startup trends that shaped the Midwest in 2018We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an...venturebea...
09.02.2018Stanford spin-out Zenflow raises $31M to join the megamarket...In a phone interview, Damiano said the startup “threw out a broad net” for funding and between 2015 ...medcitynew...
03.12.2015NxThera Completes $40M FundingNxThera, Inc., a Maple Grove, Minnesota-based medical device company advancing the application of it...finsmes.co...
04.03.2014NxThera closes $20M Series C roundNxThera said it closed a $20 million Series C round that topped its initial $18 million target. Map...massdevice...
27.02.2014NxThera Completes Series C FinancingNxThera, Inc., a Maple Grove, Minnesota-based medical device company developing endourology applicat...finsmes.co...
15.08.2013NxThera Raises $18.2M in Series C FinancingNxThera, Inc., a Maple Grove, Minnesota-based medical device company focused on the development of i...finsmes.co...
15.08.2013NxThera closes $18M Series C, wins CE Mark for Rezum prostat...NxThera said it closed on a Series C round worth $18.2 million and won CE Mark approval for its Rezu...massdevice...
Show more